Advertisement
Screener

CHEMBIO DIAGNOSTICS, INC. Restructuring Costs and Asset Impairment Charges

CHEMBIO DIAGNOSTICS, INC. Restructuring Costs and Asset Impairment Charges

CHEMBIO DIAGNOSTICS, INC. reported Restructuring Costs and Asset Impairment Charges of $3.24 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.

Discontinued › Cash Flow › Operating Activities

us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2023-03-29

  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for the quarter ending 2022-12-31 was $82.76K, a 98.20% decline year-over-year.
  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for the quarter ending 2022-09-30 was $110.25K, a 72.21% decline year-over-year.
  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for the quarter ending 2022-03-31 was $3.04M, a 3562.64% increase year-over-year.
  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for fiscal 2022 was $3.24M, a 54.08% decline from fiscal 2021.
  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for fiscal 2021 was $7.05M, a 527.97% increase from fiscal 2020.
  • CHEMBIO DIAGNOSTICS, INC. restructuring costs and asset impairment charges for fiscal 2020 was $1.12M.
Period endRestructuring Costs and Asset Impairment Charges 3 monthRestructuring Costs and Asset Impairment Charges 6 monthRestructuring Costs and Asset Impairment Charges 9 monthRestructuring Costs and Asset Impairment Charges 12 month
2022-12-31$82.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$193.01K
derived: sum of 2 quarters · filed 2023-03-29
$193.01K
derived: sum of 3 quarters · filed 2023-03-29
$3.24M
10-K · filed 2023-03-29
2022-09-30$110.25K
10-Q · filed 2022-11-03
$110.25K
derived: sum of 2 quarters · filed 2022-11-03
$3.15M
10-Q · filed 2022-11-03
$7.76M
derived: sum of 4 quarters · filed 2023-03-29
2022-06-30$0.00
10-Q · filed 2022-08-05
$3.04M
10-Q · filed 2022-08-05
$7.65M
derived: sum of 3 quarters · filed 2023-03-29
$8.05M
derived: sum of 4 quarters · filed 2023-03-29
2022-03-31$3.04M
10-Q · filed 2022-05-05
$7.65M
derived: sum of 2 quarters · filed 2023-03-29
$8.05M
derived: sum of 3 quarters · filed 2023-03-29
$10.01M
derived: sum of 4 quarters · filed 2023-03-29
2021-12-31$4.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$5.00M
derived: sum of 2 quarters · filed 2023-03-29
$6.96M
derived: sum of 3 quarters · filed 2023-03-29
$7.05M
10-K · filed 2023-03-29
2021-09-30$396.74K
10-Q · filed 2022-11-03
$2.36M
derived: sum of 2 quarters · filed 2022-11-03
$2.44M
10-Q · filed 2022-11-03
$2.44M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$1.96M
10-Q · filed 2022-08-05
$2.04M
10-Q · filed 2022-08-05
$2.04M
derived: sum of 3 quarters · filed 2022-08-05
$2.06M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$83.09K
10-Q · filed 2022-05-05
$83.09K
derived: sum of 2 quarters · filed 2022-05-05
$94.74K
derived: sum of 3 quarters · filed 2022-05-05
$482.28K
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$11.65K
derived: sum of 2 quarters · filed 2022-03-03
$399.19K
derived: sum of 3 quarters · filed 2022-03-03
$1.12M
10-K · filed 2022-03-03
2020-09-30$11.65K
10-Q · filed 2021-11-05
$399.19K
derived: sum of 2 quarters · filed 2021-11-05
$1.12M
10-Q · filed 2021-11-05
2020-06-30$387.54K
10-Q · filed 2021-08-09
$1.11M
10-Q · filed 2021-08-09